Publication:
The role of dual-phase Tc-99m MIBI in the evaluation of potentially operable lesions detected by bone scanning in fibrous dysplasia: a long-term prospective follow-up study

dc.contributor.authorsOnes, Tunc; Erol, Bulent; Aras, Mustafa; Dede, Fuat; Erdil, Tanju Yusuf; Inanir, Sabahat; Turoglu, Halil Turgut
dc.date.accessioned2022-03-12T18:05:16Z
dc.date.accessioned2026-01-10T16:56:40Z
dc.date.available2022-03-12T18:05:16Z
dc.date.issued2012
dc.description.abstractPurpose The aim of this study was to determine the role of whole-body Tc-99m MOP bone scintigraphy (BSc) with dual-phase Tc-99m MIBI scintigraphy (DPMSc) in the assessment of fibrous dysplasia (FD) and the value of DPMSc in the detection of potentially operable lesions for guiding surgical treatment. Methods Twelve patients with histopathologically confirmed FD were evaluated with BSc and DPMSc. The patients were clinically followed up for a mean duration of 75 months. BSc images have been used as a guide to identify the site and the extent of the skeletal involvement The symptomatic lesions were evaluated with DPMSc. Results Forty-three lesions were evaluated in 12 patients. BSc showed increased uptake in all of the lesions, whereas DPMSc findings correlated more accurately with the symptoms. Fifteen symptomatic lesions showed increased Tc-99m MIBI uptake on DPMSc, especially in the early phase of DPMSc. The sensitivity, specificity and accuracy values for the early phase in detecting the symptomatic lesions were 100 and 93%, and for delayed phase were 100 and 98%, respectively. Conclusion BSc is useful in determining the site and extent of the skeletal involvement, especially in polyostotic FD. It seems that the potentially operable symptomatic lesions may be evaluated more accurately with DPMSc as compared with BSc. In addition, it seems that DPMSc findings correlate with the symptoms of FD, and this relationship may have a role in improving the preoperative assessment for guiding surgical treatment DPMSc could be useful in the work-up of symptomatic patients if our results are validated in a larger patient series. Nucl Med Commun 33:288-296 (C) 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
dc.identifier.doi10.1097/MNM.0b013e32834eac86
dc.identifier.eissn1473-5628
dc.identifier.issn0143-3636
dc.identifier.pubmed22198723
dc.identifier.urihttps://hdl.handle.net/11424/230651
dc.identifier.wosWOS:000300029100011
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofNUCLEAR MEDICINE COMMUNICATIONS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectfibrous dysplasia
dc.subjectradionuclide imaging
dc.subjectTc-99m MIBI
dc.subjectTc-99m MDP
dc.subjectMCCUNE-ALBRIGHT-SYNDROME
dc.subjectMAXILLARY SINUS
dc.subjectSCINTIGRAPHY
dc.subjectCYST
dc.subjectCT
dc.subjectSECONDARY
dc.subjectDISEASE
dc.subjectSURGERY
dc.subjectPATIENT
dc.subjectSKULL
dc.titleThe role of dual-phase Tc-99m MIBI in the evaluation of potentially operable lesions detected by bone scanning in fibrous dysplasia: a long-term prospective follow-up study
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage296
oaire.citation.issue3
oaire.citation.startPage288
oaire.citation.titleNUCLEAR MEDICINE COMMUNICATIONS
oaire.citation.volume33

Files